As shown, there is 3 fold increase in anti-gal IgG, in patients with Stage 1–2 fibrosis as compared to normal serum and close to a five fold increase in anti-gal IgA, IgG and IgM in patients with Stage 5–6 fibrosis (cirrhosis). This evidence concerns the gene CD79A and Cirrhosis.